Institute For Wealth Management, Llc. Viking Therapeutics, Inc. Transaction History
Institute For Wealth Management, Llc.
- $788 Million
- Q4 2024
A detailed history of Institute For Wealth Management, Llc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Institute For Wealth Management, Llc. holds 80,602 shares of VKTX stock, worth $2.38 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
80,602
Previous 36,237
122.43%
Holding current value
$2.38 Million
Previous $2.29 Million
41.37%
% of portfolio
0.41%
Previous 0.29%
Shares
10 transactions
Others Institutions Holding VKTX
# of Institutions
466Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$300 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$178 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$145 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$76.6 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$63.7 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.26B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...